Sinovac COVID-19 vaccine collaboration with Butantan approved by Brazilian regulator for Phase III Trial

Sinovac Biotech’s partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines, has reached a milestone as it moved one step further to our commitment to developing vaccines for global use after getting the approval for Phase 3 trial from Brazilian National Regulatory Agency, Anvisa.

Read more